Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,24207,990,1.19 [1.03-1.36],0.0153206000211212
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24117,197,1.41 [1.05-1.89],0.023755494693263
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26126,190,1.33 [0.98-1.81],0.0653693530576978
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18449,771,1.02 [0.87-1.19],0.8208168979170313
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26056,120,1.66 [1.14-2.41],0.0084586600649147
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,24984,83,1.30 [0.82-2.07],0.268981036585058
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27500,119,1.64 [1.12-2.38],0.0101772531652984
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27496,80,1.52 [0.96-2.40],0.0759250770619716
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24353,64,1.18 [0.70-2.00],0.5370095525904168
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,26829,120,1.72 [1.18-2.49],0.0044597280312147
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26779,70,1.23 [0.75-2.03],0.413932228959517
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27583,79,1.25 [0.77-2.02],0.3638660830715461
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27546,97,1.01 [0.66-1.56],0.9467998939413208
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27541,92,0.98 [0.63-1.52],0.9143929366289508
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Mycoses,27201,64,0.67 [0.40-1.14],0.1435346902513554
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26394,440,1.18 [0.96-1.45],0.1094150353998007
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26084,130,1.14 [0.79-1.66],0.4815359249881648
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26260,306,1.22 [0.96-1.55],0.1106555640133983
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",22557,52,0.93 [0.52-1.67],0.8150476096420726
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22569,64,nan [nan-nan],
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",22764,259,1.03 [0.78-1.35],0.8514685901498134
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",22772,267,nan [nan-nan],
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",23183,678,1.44 [1.22-1.70],1.652592995669481e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22556,51,0.96 [0.53-1.76],0.8973829139717662
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,24716,1028,1.30 [1.14-1.49],0.0001341220425026
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26493,294,1.13 [0.88-1.44],0.3511747378002666
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27236,109,1.18 [0.79-1.77],0.4163029017829718
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27679,91,1.08 [0.69-1.68],0.7395215571861984
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Rectum,27456,59,1.03 [0.59-1.79],0.9128573985123168
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27678,70,1.56 [0.95-2.58],0.0820129780366683
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Stomach,27726,55,1.79 [1.02-3.13],0.040867761749116
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm,27499,270,1.07 [0.82-1.38],0.6261090496158337
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27673,109,1.02 [0.68-1.55],0.9064699671112324
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27672,103,1.20 [0.79-1.81],0.3985275820793226
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27605,69,1.12 [0.67-1.87],0.6729009952511463
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Haemangioma, any site",27607,68,1.16 [0.69-1.95],0.5699698594753133
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanocytic naevi,27513,269,0.94 [0.72-1.23],0.6613725776865702
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,27684,120,1.11 [0.75-1.66],0.5937334735464261
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Other benign neoplasms of skin,27579,233,0.91 [0.69-1.21],0.5093172331292763
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of breast,27662,138,1.03 [0.72-1.49],0.8630475706652465
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Leiomyoma of uterus,27159,1001,0.93 [0.81-1.07],0.2919213284435727
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26308,269,1.71 [1.33-2.20],3.518283698993226e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26030,451,1.39 [1.14-1.70],0.0012534783254797
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26030,451,1.39 [1.14-1.70],0.0012534783254797
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),24486,420,1.58 [1.28-1.94],1.7040406048278988e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27148,99,1.23 [0.80-1.90],0.3397906824238367
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27368,107,1.55 [1.03-2.34],0.0355540002549302
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22974,917,1.18 [1.02-1.36],0.0260681242338768
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,25388,906,1.02 [0.88-1.17],0.8250253597977828
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,25871,122,1.26 [0.86-1.84],0.2295443190270808
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26705,59,1.87 [1.11-3.16],0.0193319047818425
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25858,109,1.34 [0.90-2.01],0.1482898082007924
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26163,414,1.17 [0.95-1.44],0.1304040879761894
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26155,406,1.16 [0.94-1.42],0.1751869741283992
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25631,197,1.10 [0.79-1.51],0.5792405058916411
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25634,194,1.07 [0.77-1.47],0.7031949407776583
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22781,724,1.17 [1.00-1.38],0.0548879258817927
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22140,83,1.57 [0.98-2.50],0.0580479088227489
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,22728,671,1.16 [0.98-1.37],0.0919254240145589
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22109,52,0.94 [0.51-1.70],0.8277316091195498
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",22125,68,1.30 [0.77-2.18],0.3322464875601592
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Any mental disorder,23376,619,0.97 [0.82-1.16],0.7732817673473252
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22876,119,0.68 [0.45-1.02],0.0613188936403937
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27478,81,0.63 [0.39-1.01],0.0552040597318793
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27521,49,0.78 [0.43-1.41],0.408184771341231
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,26264,39,0.76 [0.37-1.54],0.4426473271048745
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",27674,39,0.76 [0.38-1.51],0.4329936139756118
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",22796,39,0.72 [0.35-1.48],0.3757343246417451
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Alcohol dependence,26251,26,0.82 [0.35-1.93],0.6469164715408442
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Smoking dependency,26146,35,0.97 [0.47-2.00],0.9318737130219116
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22800,43,0.42 [0.22-0.83],0.0118509192298919
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",23141,384,1.15 [0.92-1.43],0.2139333020799769
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Depression,25708,341,1.12 [0.89-1.42],0.3190967547418718
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Depression or dysthymia,22922,300,1.29 [1.01-1.65],0.0447889346087847
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",22905,148,1.04 [0.73-1.48],0.8323268745069001
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Other anxiety disorders,25797,76,1.09 [0.67-1.78],0.7259639398075433
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Neurological diseases,23883,1637,1.00 [0.90-1.12],0.9655428534113676
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,21838,181,1.11 [0.80-1.54],0.530465580187782
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27531,151,1.19 [0.84-1.70],0.3291988922525619
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26366,424,1.02 [0.83-1.26],0.8321052459654892
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Epilepsy,26079,137,0.93 [0.65-1.34],0.694384881940892
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Migraine,26070,128,1.42 [0.97-2.07],0.0679693272734493
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27276,118,1.37 [0.93-2.03],0.1133670400788942
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27016,59,1.26 [0.74-2.16],0.3963171070382928
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other sleep disorders,26039,97,0.78 [0.51-1.20],0.2568654920565926
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Sleep apnoea,27303,70,0.81 [0.49-1.35],0.4150695080752102
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26335,863,0.94 [0.81-1.08],0.3743277570749158
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25594,122,0.84 [0.57-1.24],0.3737177738647745
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26022,550,0.91 [0.75-1.09],0.297401488307332
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27461,76,0.91 [0.56-1.47],0.6921290572300401
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Hemiplegia,27442,57,0.94 [0.54-1.64],0.8273691081542615
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other neurological diseases,27231,125,1.04 [0.71-1.52],0.8434293741785094
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",26983,429,1.14 [0.93-1.40],0.2018757816282991
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26805,251,1.13 [0.87-1.48],0.3631567058154771
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26627,73,1.03 [0.63-1.70],0.8995440636448576
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26688,134,1.19 [0.83-1.72],0.3367584497541406
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26660,106,1.24 [0.83-1.86],0.2974723548505272
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23566,177,0.98 [0.71-1.34],0.8822800118227785
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23804,415,1.08 [0.88-1.33],0.4710639330155665
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26670,184,0.93 [0.68-1.28],0.6572345464295465
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27453,33,1.41 [0.69-2.88],0.3405047446502875
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1782,33,1.47 [0.75-2.88],0.266222308279471
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",25704,33,1.42 [0.69-2.92],0.3395941449805443
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27012,94,1.32 [0.86-2.04],0.2078166122236837
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,26971,53,1.67 [0.95-2.94],0.0742992481377198
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",26877,98,0.63 [0.40-0.97],0.0380976802529675
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27144,102,1.29 [0.85-1.95],0.2274385669296932
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27601,129,0.86 [0.59-1.25],0.4221891558033975
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,26923,104,1.31 [0.87-1.98],0.1988281442936836
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20386,2801,1.09 [1.00-1.20],0.0623661700121017
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27140,77,1.38 [0.86-2.21],0.180453171727807
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21414,2064,1.07 [0.96-1.19],0.211198854241324
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypertension,21435,2085,1.11 [1.00-1.23],0.0618905686612712
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19400,50,,
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26017,729,1.22 [1.04-1.42],0.0150966355041611
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Angina pectoris,25796,508,1.15 [0.95-1.39],0.1389719386326978
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27050,151,1.09 [0.78-1.53],0.6007182007407252
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27128,229,1.19 [0.91-1.57],0.2051107276645094
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27656,28,1.89 [0.90-3.99],0.0927013499758086
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25384,96,1.29 [0.84-1.97],0.2380235471765033
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,25754,477,1.39 [1.14-1.68],0.000831794553554
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Pulmonary embolism,26934,97,1.71 [1.13-2.58],0.011345668138541
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27035,216,1.26 [0.95-1.67],0.1123453742903395
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Secondary right heart disease,26933,96,0.90 [0.58-1.39],0.6237917937052448
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,26933,96,0.90 [0.58-1.39],0.6237917937052448
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19443,93,0.86 [0.54-1.36],0.5097188362361971
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Cardiomyopathy,24063,38,2.00 [1.03-3.91],0.0418752695561972
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Conduction disorders,24104,79,1.11 [0.69-1.81],0.6625999408265989
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16629,103,1.00 [0.64-1.56],0.9969040438839732
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16806,280,2.49 [1.93-3.22],2.30578508720458e-12
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other arrhythmias,24075,50,1.25 [0.68-2.28],0.4727382779669996
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24083,58,1.36 [0.78-2.38],0.278739435465352
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Heart failure, strict",26875,101,2.51 [1.72-3.66],1.6412152813783583e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",26934,130,1.46 [1.02-2.10],0.0407221000112728
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",26976,98,1.79 [1.19-2.67],0.0048462399382498
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27043,86,1.86 [1.22-2.85],0.0042489067469952
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26731,71,0.93 [0.56-1.55],0.7811568630541766
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26773,113,1.40 [0.94-2.07],0.0963079697595792
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26086,132,0.99 [0.69-1.44],0.9735902088324948
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26059,105,1.20 [0.79-1.81],0.3877742842246594
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27511,102,1.28 [0.85-1.93],0.2411025779346962
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Varicose veins,26568,614,0.96 [0.80-1.14],0.617714372044602
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypotension,26566,96,1.56 [1.02-2.39],0.0381310486261258
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22541,2120,0.85 [0.77-0.94],0.0017939990111766
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27506,128,0.96 [0.66-1.40],0.8282515763533312
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26070,198,0.87 [0.64-1.18],0.3833281121654219
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26050,178,0.87 [0.63-1.21],0.4128939302637282
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,26815,234,0.78 [0.59-1.04],0.0883190875193373
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,26807,226,0.74 [0.56-0.99],0.0426476492589576
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26948,571,1.10 [0.92-1.31],0.3038346827591444
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Chronic sinusitis,26490,113,1.40 [0.94-2.08],0.0966719358712635
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Nasal polyp,26460,83,0.82 [0.51-1.33],0.4242625629060896
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26738,361,1.14 [0.91-1.42],0.2595446162446287
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Deviated nasal septum,26521,144,1.75 [1.24-2.48],0.001550222004948
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13357,66,1.13 [0.65-1.95],0.6659466455382765
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,24755,1164,0.72 [0.63-0.82],8.599931607241913e-07
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Early onset COPD,26657,159,0.48 [0.34-0.67],1.668908980288423e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26677,179,0.51 [0.37-0.70],3.790308974821338e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26677,179,0.51 [0.37-0.70],3.790308974821338e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25661,999,0.76 [0.66-0.87],8.360398183246561e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Asthma,20591,999,0.74 [0.65-0.86],6.00459107138808e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",20400,999,0.75 [0.65-0.86],8.260843971078568e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",20576,984,0.74 [0.64-0.86],4.698036935714332e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27395,84,0.36 [0.22-0.57],1.6728528439816383e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Interstitial lung disease,25918,63,0.27 [0.16-0.47],2.4790990522565774e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27468,63,0.27 [0.16-0.47],2.80757622417776e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,25911,56,0.26 [0.15-0.47],5.719241208563704e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pleural effusion,25870,90,1.31 [0.84-2.04],0.2306198981419587
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other diseases of pleura,25975,195,0.84 [0.61-1.14],0.2560429841410613
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26552,92,0.70 [0.45-1.10],0.1205825097366813
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19151,6049,1.01 [0.94-1.08],0.8314359926019486
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27144,475,1.03 [0.84-1.26],0.7760260912036746
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27682,105,1.63 [1.06-2.51],0.0252877601756761
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Impacted teeth,27687,94,1.58 [1.00-2.49],0.0508854484526179
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Dental caries,26774,105,1.02 [0.68-1.53],0.941738525788874
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26787,118,1.01 [0.68-1.50],0.9728177140074972
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27672,115,1.58 [1.05-2.39],0.0287951411830822
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26786,117,0.92 [0.62-1.37],0.674439542288033
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26479,78,0.65 [0.40-1.06],0.0851217082209412
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27582,49,0.82 [0.44-1.50],0.5094710806838056
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,20933,223,0.96 [0.72-1.28],0.7616545931674042
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23037,2327,1.04 [0.95-1.14],0.4279054926676443
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oesophagitis,20998,288,0.96 [0.74-1.24],0.762211065261462
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21447,737,1.11 [0.95-1.31],0.2011970888937526
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20786,76,0.90 [0.55-1.47],0.6622078849146686
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20846,136,1.59 [1.10-2.28],0.0125442640698331
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20751,41,1.25 [0.65-2.40],0.4971368965148907
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastric ulcer,20859,149,1.01 [0.71-1.44],0.9490621701384332
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Duodenal ulcer,20785,75,0.96 [0.58-1.57],0.8608405799841393
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27633,53,0.76 [0.43-1.36],0.3551259646159611
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Chronic gastritis,20846,136,1.24 [0.86-1.78],0.2466028468392002
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21558,848,1.09 [0.94-1.27],0.2518391348898591
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of appendix,27557,147,0.76 [0.53-1.09],0.1329486322746888
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Functional dyspepsia,21292,582,1.06 [0.88-1.27],0.5319265370049231
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,20891,181,0.94 [0.68-1.30],0.7168737094626273
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27591,144,1.19 [0.83-1.71],0.3341071781633473
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute appendicitis,27529,119,0.76 [0.51-1.14],0.1795472733858863
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Hernia,24801,1197,0.97 [0.85-1.10],0.6350360464470814
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Inguinal hernia,23673,69,0.87 [0.52-1.46],0.6025808485767778
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Umbilical hernia,23674,70,0.87 [0.52-1.44],0.5874638106130816
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ventral hernia,23712,108,1.02 [0.68-1.53],0.9261772686463872
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24559,955,0.99 [0.86-1.14],0.9105237614779016
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26617,922,1.13 [0.98-1.30],0.089803194972549
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of intestines,21933,2216,1.04 [0.95-1.15],0.3798887643584013
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27369,62,1.09 [0.63-1.88],0.7708900843399638
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27649,90,1.60 [1.03-2.50],0.0373535735511008
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Crohn disease,25785,90,1.62 [1.04-2.54],0.0334395670088746
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25760,65,2.24 [1.35-3.71],0.0017067408593272
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27575,133,1.36 [0.94-1.96],0.1013744554720767
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ulcerative colitis,25828,133,1.37 [0.95-1.99],0.090326718505659
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25816,121,1.35 [0.92-1.99],0.1246533036629025
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26479,784,1.13 [0.97-1.31],0.1284444192914534
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26468,773,1.14 [0.97-1.32],0.1078736149179143
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19825,108,1.13 [0.75-1.72],0.5549329480404199
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Intestinal stricture,27244,108,1.12 [0.74-1.70],0.5806039066767732
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19785,68,1.12 [0.66-1.89],0.68345739263204
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20397,680,0.95 [0.80-1.12],0.5275706218793883
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,19963,246,0.95 [0.72-1.25],0.7167837366812335
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,20111,394,1.38 [1.11-1.72],0.0035993999551654
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Constipation,25996,353,1.35 [1.08-1.69],0.0091107387578284
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27188,126,0.89 [0.60-1.30],0.5355632306143625
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19843,126,1.44 [0.98-2.12],0.0656970505118326
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19765,48,0.94 [0.50-1.75],0.8371407316657746
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20622,905,1.01 [0.87-1.17],0.9070167336678864
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of intestine,19952,235,0.73 [0.55-0.97],0.0284736712007667
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27170,108,0.80 [0.53-1.22],0.2996340438416345
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of liver,26916,102,2.11 [1.43-3.12],0.0001657151125369
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of liver,26867,53,1.38 [0.78-2.45],0.266845421687048
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26126,880,1.07 [0.92-1.24],0.3601732435638959
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Cholelithiasis,25981,735,1.05 [0.90-1.24],0.5178638612251577
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Cholecystitis,25378,132,0.88 [0.61-1.28],0.5063685721356158
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25314,68,1.49 [0.89-2.47],0.1268512263326815
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute pancreatitis,25308,62,1.61 [0.96-2.72],0.0737364097273059
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27561,62,1.58 [0.94-2.66],0.0812019178112205
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26314,306,0.87 [0.68-1.12],0.2771471846824029
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26112,104,0.54 [0.35-0.83],0.0047404747664317
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Coeliac disease,26097,89,0.47 [0.29-0.75],0.001546899816766
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26047,39,1.38 [0.70-2.69],0.3526999921152675
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26176,168,1.03 [0.75-1.43],0.8420853915410969
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,GI-bleeding,26166,158,0.99 [0.71-1.39],0.9608861703273835
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,24528,1624,1.03 [0.92-1.15],0.5958218210646861
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27251,112,0.89 [0.59-1.33],0.5638787258745412
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27258,461,1.00 [0.81-1.22],0.968695993190876
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26121,696,1.09 [0.93-1.29],0.2985647425824559
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26886,326,0.98 [0.77-1.24],0.8805709651006997
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26631,71,0.60 [0.36-1.00],0.0488830407227857
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26767,207,1.21 [0.90-1.62],0.2020939622558063
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27429,89,1.05 [0.67-1.64],0.8213704742562397
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27402,62,1.11 [0.66-1.88],0.6990272462116931
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27390,50,1.13 [0.63-2.03],0.6830955229402162
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27445,55,1.04 [0.58-1.84],0.9064413031884316
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27442,52,1.13 [0.63-2.04],0.6797051636322852
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26856,59,1.45 [0.85-2.47],0.1756731495855931
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27157,360,0.96 [0.76-1.20],0.6946453414977836
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25529,104,1.01 [0.66-1.54],0.9773922330175528
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25580,155,1.29 [0.91-1.82],0.1497185557114088
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25536,111,1.24 [0.82-1.86],0.3041499568138875
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25680,255,0.97 [0.74-1.28],0.8454062518731345
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25656,231,1.03 [0.77-1.37],0.8525641152436069
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19523,4427,1.02 [0.94-1.09],0.6996234741280372
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21278,2557,0.99 [0.90-1.08],0.8038388699151442
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,24881,1330,1.08 [0.95-1.21],0.2271156983100921
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18931,210,0.97 [0.72-1.31],0.8567051912538208
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19239,518,1.06 [0.87-1.28],0.5730456525661111
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27135,201,0.92 [0.68-1.24],0.5798927435265251
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27152,184,1.01 [0.74-1.38],0.9561047408815224
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19967,1246,0.95 [0.84-1.08],0.4477393800369286
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",22692,1246,0.95 [0.84-1.08],0.4737891825301965
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18733,12,2.52 [0.88-7.17],0.0836615083292808
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27514,12,2.63 [0.90-7.67],0.0761216976575127
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19001,280,1.04 [0.81-1.34],0.7583428057505778
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18810,89,0.75 [0.48-1.19],0.2232739554491284
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19029,308,0.73 [0.57-0.94],0.014593823261531
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27524,156,0.75 [0.53-1.05],0.0975801792823676
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19213,492,0.94 [0.77-1.15],0.543219834601819
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19216,495,1.08 [0.88-1.31],0.4690156448474182
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20154,1433,1.01 [0.90-1.14],0.8380444793601919
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18829,108,0.68 [0.44-1.03],0.0707421736561046
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19149,428,0.84 [0.68-1.05],0.1214821796974167
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18804,83,1.00 [0.62-1.62],0.994803483342804
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18829,108,0.53 [0.34-0.81],0.003498037238578
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19097,376,1.06 [0.85-1.33],0.5859560941428985
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19040,319,1.08 [0.85-1.38],0.5191406160555153
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20644,303,1.07 [0.84-1.37],0.5895171010094629
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26892,224,0.95 [0.72-1.26],0.7280270654691137
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26763,95,1.70 [1.12-2.59],0.0131621182737079
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,23719,83,0.48 [0.30-0.78],0.0028914051780024
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,23944,308,1.10 [0.86-1.39],0.4612726310387209
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,24667,1031,1.05 [0.92-1.20],0.4736785193995239
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,23854,218,1.10 [0.82-1.46],0.5310792895135347
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23713,77,0.74 [0.46-1.21],0.2341321338226311
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",24455,819,1.09 [0.94-1.27],0.2694623139592367
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23688,52,1.07 [0.59-1.94],0.8317186039753681
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,23882,246,0.92 [0.70-1.21],0.5334635170113996
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23739,103,0.70 [0.45-1.08],0.1045763562137532
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23724,88,1.10 [0.70-1.73],0.6851970882946012
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,23795,159,0.96 [0.68-1.35],0.8111297975899124
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23713,77,1.11 [0.68-1.79],0.6785658816354879
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,23992,356,1.20 [0.96-1.51],0.1086863816931842
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,23935,384,0.99 [0.79-1.23],0.918726082585336
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23626,75,0.75 [0.45-1.23],0.2481728594385424
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23660,109,0.87 [0.57-1.31],0.5004471658183651
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23691,140,1.17 [0.82-1.68],0.3810062291053816
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23587,36,0.90 [0.44-1.86],0.7808607686022414
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23609,58,0.84 [0.48-1.50],0.5598875315356762
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23593,42,1.09 [0.56-2.13],0.7952888628481116
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,23834,283,1.26 [0.98-1.62],0.0688741588294694
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23612,61,1.28 [0.75-2.18],0.3670505088627466
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23620,69,0.72 [0.43-1.21],0.2146285608934579
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23692,141,1.06 [0.74-1.51],0.762287178361519
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23633,82,0.79 [0.49-1.29],0.3506987453813629
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24088,537,1.17 [0.97-1.41],0.0998456720385222
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,23736,185,1.16 [0.85-1.59],0.3533841653012456
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,23844,293,1.18 [0.92-1.52],0.1876097962666778
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,24949,239,1.23 [0.94-1.62],0.1302583004148648
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,25203,493,1.15 [0.95-1.40],0.1509238751647921
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24751,41,1.45 [0.75-2.80],0.2709506184337543
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24777,67,0.91 [0.54-1.55],0.7388915029055299
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,24828,118,1.07 [0.72-1.59],0.7410664703290806
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,22606,6153,1.12 [1.05-1.20],0.0004097785500803
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,25229,202,4.07 [3.06-5.42],6.979599160564064e-22
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25072,45,1.41 [0.74-2.70],0.2977324752455201
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Acute renal failure,25400,35,4.97 [2.53-9.77],3.311668743149928e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,25413,48,,
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25406,41,4.49 [2.38-8.49],3.780665492254517e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27470,131,1.29 [0.89-1.87],0.1722592523706875
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27348,67,2.36 [1.48-3.76],0.000328022443654
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27438,99,1.37 [0.89-2.09],0.1481700799711229
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27376,37,1.00 [0.50-2.00],0.9926788713941116
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25477,1267,1.14 [1.01-1.29],0.0384770587185145
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Cystitis,24347,137,1.25 [0.87-1.80],0.2325953399204766
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24298,88,1.29 [0.82-2.03],0.2642022636789204
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24377,167,1.05 [0.75-1.46],0.7762537320660156
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24299,89,1.36 [0.87-2.12],0.1784878559244498
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25210,1000,1.18 [1.03-1.35],0.0208950553667758
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27401,486,1.14 [0.93-1.38],0.198628963324501
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27065,150,1.40 [0.99-1.98],0.0560544369350641
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,27087,172,1.19 [0.86-1.64],0.3072720688155221
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27029,114,0.94 [0.63-1.41],0.7608656918417346
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27341,558,0.94 [0.78-1.13],0.4998312140117125
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,26917,134,0.73 [0.50-1.07],0.1105778836423642
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27031,248,1.04 [0.79-1.37],0.784510384456258
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,25264,4595,0.98 [0.91-1.05],0.5141838059154158
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Endometriosis,21031,362,0.89 [0.71-1.13],0.3540928178292515
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20767,98,1.07 [0.68-1.69],0.7648967960994915
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20836,167,0.86 [0.61-1.21],0.3799501391119008
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21466,797,0.85 [0.73-1.00],0.0483716569383822
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21076,407,0.99 [0.79-1.23],0.8936226310357949
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21632,963,1.00 [0.87-1.16],0.9548019091258608
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20983,314,1.03 [0.81-1.32],0.7868236250883993
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21112,443,1.08 [0.88-1.33],0.4575527028942027
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20770,101,1.15 [0.74-1.80],0.5375254587699704
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20855,186,0.96 [0.70-1.33],0.8256598051457533
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27677,265,0.98 [0.75-1.28],0.8846401386585567
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27689,251,0.98 [0.74-1.28],0.858820472730154
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27715,139,1.02 [0.70-1.48],0.9044762001722908
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27704,153,1.04 [0.73-1.48],0.8306064452752051
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20817,148,1.34 [0.95-1.90],0.0952499592922523
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20781,112,0.93 [0.62-1.40],0.7412605674973269
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20814,145,0.62 [0.43-0.89],0.0102035367914674
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Irregular menses,27609,469,1.12 [0.91-1.37],0.2906823648567951
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",22014,1345,1.05 [0.93-1.19],0.3977006672026356
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21543,874,1.06 [0.91-1.23],0.4642288008402774
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27695,195,1.21 [0.89-1.65],0.232217006485651
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21135,466,1.09 [0.89-1.33],0.413961691074858
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20998,329,0.98 [0.76-1.25],0.8467730112743929
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21573,904,1.02 [0.88-1.18],0.7662737080693636
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Female infertility,20784,115,1.17 [0.76-1.80],0.4809898878867346
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20777,108,1.07 [0.68-1.67],0.7748652458220027
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27713,876,0.95 [0.80-1.13],0.5908042109636349
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27717,1195,0.91 [0.78-1.06],0.2243205126055107
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27714,475,0.71 [0.57-0.88],0.0014762555360763
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,27376,137,0.59 [0.40-0.88],0.0091341590019015
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,27426,187,0.88 [0.63-1.23],0.4510398946811575
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,27404,165,0.66 [0.47-0.94],0.0211715860078633
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27731,167,0.83 [0.58-1.19],0.3124294783693979
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27733,164,0.82 [0.57-1.18],0.2930652487394969
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27730,415,1.07 [0.85-1.35],0.5759883783453681
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,27438,123,1.26 [0.83-1.90],0.2737716271794387
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27544,229,1.01 [0.74-1.37],0.9491349190936544
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,26985,148,1.08 [0.73-1.60],0.7000422847441825
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,27037,200,0.80 [0.57-1.11],0.1777221789921347
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,27086,249,0.95 [0.70-1.28],0.7381317474029865
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,26986,149,0.90 [0.61-1.32],0.5847475774758328
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,26976,139,1.00 [0.67-1.49],0.9941082247414702
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,26987,150,0.80 [0.55-1.17],0.2523806367787506
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26754,232,0.82 [0.60-1.13],0.2219139062535869
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26957,435,0.98 [0.78-1.24],0.8867896654018115
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,27189,667,0.96 [0.79-1.17],0.6697428940218658
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27734,166,0.84 [0.58-1.20],0.333475570003913
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,26276,126,0.86 [0.57-1.31],0.4884011784187951
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26623,101,0.76 [0.48-1.20],0.2353838901618866
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27742,343,0.82 [0.64-1.06],0.1388066772272526
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27662,263,0.77 [0.57-1.03],0.0761885384640386
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27730,251,0.87 [0.65-1.17],0.3714765901140787
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27720,241,0.87 [0.64-1.17],0.3569214278055398
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27434,45,1.09 [0.59-2.01],0.7795222448167358
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24807,648,1.01 [0.85-1.20],0.8856062538605594
